alpha smooth muscle Actin (ACTA2) Rabbit Polyclonal Antibody
CAT#: TA347823
Rabbit Polyclonal Anti-alpha-SMA antibody
Need it in bulk or conjugated?
Get a free quote
CNY 1,999.00
CNY 3,280.00
Cited in 3 publications. |
CNY 300.00
CNY 1,430.00
CNY 2,900.00
CNY 6,650.00
CNY 3,080.00
CNY 3,080.00
Specifications
Product Data | |
Applications | WB |
Recommend Dilution | WB: 1:500-1:1000 |
Reactivity | Human, Mouse, Rat |
Host | Rabbit |
Clonality | Polyclonal |
Immunogen | The immunogen for anti-alpha-SMA antibody: Synthetic peptide corresponding to N terminal residues of Human alpha smooth muscle Actin. |
Formulation | Rabbit IgG in phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. Store at -20?. Stable for 12 months from date of receipt |
Concentration | lot specific |
Conjugation | Unconjugated |
Storage Condition | Store at -20°C as received. |
Predicted Protein Size | 45 KD |
Gene Name | actin, alpha 2, smooth muscle, aorta |
Database Link | |
Background | Defects in ACTA2 are the cause of aortic aneurysm familial thoracic type 6 (AAT6) [MIM:611788]. AATs are characterized by permanent dilation of the thoracic aorta usually due to degenerative changes in the aortic wall. They are primarily associated with a characteristic histologic appearance known as 'medial necrosis' or 'Erdheim cystic medial necrosis' in which there is degeneration and fragmentation of elastic fibers, loss of smooth muscle cells, and an accumulation of basophilic ground substance. |
Synonyms | AAT6; ACTSA; MYMY5 |
Note | alpha-SMA antibody detects endogenous levels of alpha-SMA. |
Reference Data | |
Protein Pathways | Vascular smooth muscle contraction |
Citations (3)
The use of this Antibodies has been cited in the following citations: |
---|
Type I Collagen Suspension Induces Neocollagenesis and Myodifferentiation in Fibroblasts In Vitro
,null,
BioMed Research International
,PubMed ID 34368344
[ACTA2]
|
miR-122 promotes proliferation and invasion of clear cell renal cell carcinoma by suppressing Forkhead box O3
,null,
International Journal of Oncology
,PubMed ID 30483771
[ACTA2]
|
Targeting FOSB with a cationic antimicrobial peptide, TP4, for treatment of triple-negative breast cancer
,Ting, CH;Chen, YC;Wu, CJ;Chen, JY;,
Oncotarget
,PubMed ID 27248170
[ACTA2]
|
Documents
Product Manuals |
FAQs |
SDS |
Resources
抗体相关资料 |
其它alpha smooth muscle Actin产品